Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
Clinical trial NCT05336383 · RECRUITING
Trial details
- NCT number
- NCT05336383
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-31
- Primary completion
- 2026-12-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.